Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.
2.

Anaplastic lymphoma kinase proteins and malignancy.

Pulford K, Morris SW, Mason DY.

Curr Opin Hematol. 2001 Jul;8(4):231-6. Review.

PMID:
11561161
[PubMed - indexed for MEDLINE]
3.

The t(2;5) in human lymphomas.

Kadin ME, Morris SW.

Leuk Lymphoma. 1998 Apr;29(3-4):249-56. Review.

PMID:
9684923
[PubMed - indexed for MEDLINE]
4.

Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.

Kutok JL, Aster JC.

J Clin Oncol. 2002 Sep 1;20(17):3691-702. Review.

PMID:
12202671
[PubMed - indexed for MEDLINE]
5.

Pathobiology of ALK+ anaplastic large-cell lymphoma.

Amin HM, Lai R.

Blood. 2007 Oct 1;110(7):2259-67. Epub 2007 May 22. Review.

PMID:
17519389
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Anaplastic lymphoma kinase: signalling in development and disease.

Palmer RH, Vernersson E, Grabbe C, Hallberg B.

Biochem J. 2009 May 27;420(3):345-61. doi: 10.1042/BJ20090387. Review.

PMID:
19459784
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Novel therapeutic options in anaplastic large cell lymphoma: molecular targets and immunological tools.

Merkel O, Hamacher F, Sifft E, Kenner L, Greil R; European Research Initiative on Anaplastic Large Cell Lymphoma.

Mol Cancer Ther. 2011 Jul;10(7):1127-36. doi: 10.1158/1535-7163.MCT-11-0042. Epub 2011 Jun 28. Review.

PMID:
21712478
[PubMed - indexed for MEDLINE]
Free Article
8.

What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?

Turner SD, Alexander DR.

Leukemia. 2005 Jul;19(7):1128-34. Review.

PMID:
15902287
[PubMed - indexed for MEDLINE]
9.

Anaplastic lymphoma kinase in human cancer.

Barreca A, Lasorsa E, Riera L, Machiorlatti R, Piva R, Ponzoni M, Kwee I, Bertoni F, Piccaluga PP, Pileri SA, Inghirami G; European T-Cell Lymphoma Study Group.

J Mol Endocrinol. 2011 Jul 4;47(1):R11-23. doi: 10.1530/JME-11-0004. Print 2011 Aug. Review.

PMID:
21502284
[PubMed - indexed for MEDLINE]
Free Article
10.

Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma.

Tabbò F, Ponzoni M, Rabadan R, Bertoni F, Inghirami G; European T-cell Lymphoma Study Group.

Curr Opin Hematol. 2013 Jul;20(4):374-81. doi: 10.1097/MOH.0b013e3283623c07. Review.

PMID:
23673339
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition.

Roskoski R Jr.

Pharmacol Res. 2013 Feb;68(1):68-94. doi: 10.1016/j.phrs.2012.11.007. Epub 2012 Nov 28. Review.

PMID:
23201355
[PubMed - indexed for MEDLINE]
12.

Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma.

Foyil KV, Bartlett NL.

Cancer J. 2012 Sep-Oct;18(5):450-6. Review.

PMID:
23006951
[PubMed - indexed for MEDLINE]
13.

Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review.

Costes-Martineau V, Delfour C, Obled S, Lamant L, Pageaux GP, Baldet P, Blanc P, Delsol G.

J Clin Pathol. 2002 Nov;55(11):868-71. Review.

PMID:
12401829
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity.

Lazzeri D, Agostini T, Bocci G, Giannotti G, Fanelli G, Naccarato AG, Danesi R, Tuccori M, Pantaloni M, D'Aniello C.

Clin Breast Cancer. 2011 Oct;11(5):283-96. doi: 10.1016/j.clbc.2011.03.020. Epub 2011 May 11. Review.

PMID:
21729665
[PubMed - indexed for MEDLINE]
15.

Subcellular compartmentalization of TNF receptor-1 and CD95 signaling pathways.

Tchikov V, Bertsch U, Fritsch J, Edelmann B, Schütze S.

Eur J Cell Biol. 2011 Jun-Jul;90(6-7):467-75. doi: 10.1016/j.ejcb.2010.11.002. Epub 2010 Dec 7. Review.

PMID:
21144616
[PubMed - indexed for MEDLINE]
16.

Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.

Deuel TF.

Biochim Biophys Acta. 2013 Oct;1834(10):2219-23. doi: 10.1016/j.bbapap.2013.06.004. Epub 2013 Jun 15. Review.

PMID:
23777859
[PubMed - indexed for MEDLINE]
17.

Targeting oncogenic ALK: a promising strategy for cancer treatment.

Grande E, Bolós MV, Arriola E.

Mol Cancer Ther. 2011 Apr;10(4):569-79. doi: 10.1158/1535-7163.MCT-10-0615. Review. Erratum in: Mol Cancer Ther. 2011 Aug;10(8):1529.

PMID:
21474455
[PubMed - indexed for MEDLINE]
Free Article
18.

Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Webb TR, Slavish J, George RE, Look AT, Xue L, Jiang Q, Cui X, Rentrop WB, Morris SW.

Expert Rev Anticancer Ther. 2009 Mar;9(3):331-56. doi: 10.1586/14737140.9.3.331. Review.

PMID:
19275511
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

ALK-negative anaplastic large cell lymphoma primarily involving the bronchus: a case report and literature review.

Xu X.

Int J Clin Exp Pathol. 2013 Dec 15;7(1):460-3. eCollection 2014. Review.

PMID:
24427373
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The tumor necrosis factor-related apoptosis-inducing ligand and lung cancer: still following the right TRAIL?

McGrath EE.

J Thorac Oncol. 2011 Jun;6(6):983-7. doi: 10.1097/JTO.0b013e318217b6c8. Review.

PMID:
21623278
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk